Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 915-037-6 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Repeated dose toxicity: inhalation
Administrative data
- Endpoint:
- repeated dose toxicity: inhalation
- Remarks:
- combined repeated dose and carcinogenicity
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Acceptable, well documented study report which meets basic scientific principles.
Cross-reference
- Reason / purpose for cross-reference:
- reference to same study
Data source
Reference
- Reference Type:
- publication
- Title:
- Effects of the inhalation of dusts from calcium silicate insulation materials in laboratory rats
- Author:
- Bolton R.E, Addison J, Davis J.M.E, Donaldson K, Jones A.D, Miller B.G. and A Wright
- Year:
- 1 986
- Bibliographic source:
- Env Res 39, 26-43
Materials and methods
Test guideline
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- Male Wistar SPF rats were exposed to three different calcium silicate dusts at a concentration of 10 mg/m3 for 12 months, after which some animals were killed and the others were kept for their full lifespan. Detailed histopathological and haematological examinations were carried out after the animals died.
- GLP compliance:
- not specified
- Limit test:
- no
Test material
- Reference substance name:
- Calcium silicate
- EC Number:
- 233-250-6
- EC Name:
- Calcium silicate
- Cas Number:
- 10101-39-0
- IUPAC Name:
- calcium oxosilanediolate
- Details on test material:
- Three different calcium silicate insulation materials were selected for the study. The main component of the material was the 11 Å form of the mineral tobermorite (Ca5(OH)2Si6O16*4H2O.
Calcium carbonate and quartz are used in the commercial manufacture of tobermorite, and residues are normally found in the final products.
Other components present in the calcium silcate insulation materials tested were man made mineral fibers, cellulose fibers, amorphous silica and haematite.
The three types (A, B and C) of calcium silicate insulation material were supplied as standard product slabs, 50 mm thick, which were then sawn to smaller pieces. A cloud of airborne dust was generated using a rotating wire brush.
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- Wistar SPF rats of the AF/HAN strain were used.
TEST ANIMALS
- Source: no data
- Age at study initiation: no data
- Weight at study initiation: no data
- Fasting period before study: no data
- Housing: 48 animals were placed in each of the four inhalation chambers
- Diet (e.g. ad libitum): yes (standard pellet laboratory diet)
- Water (e.g. ad libitum): tap water
- Acclimation period: no data
ENVIRONMENTAL CONDITIONS: no data
IN-LIFE DATES: From: end of 12 month exposure period To: full lifespan, however the final surviving animals from all groups were killed 19 months after the end of the dustiness phase
Administration / exposure
- Route of administration:
- inhalation: dust
- Type of inhalation exposure:
- not specified
- Vehicle:
- other: unchanged (no vehicle)
- Remarks on MMAD:
- MMAD / GSD: no data
- Details on inhalation exposure:
- INHALATION:
A rotating wire brush was used for generation of a cloud of airborne dust containing a wide range of particle sizes. A jet of compressed air was used to carry the dust into the chamber ventilation air flow. - Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
Airborne sust samples were taken regularly from each chamber throughout the exposure phase. These were used to provide estimates of the total and respirable mass concentrations, size distributions and the mineral composition of the dusts.- Duration of treatment / exposure:
- Inhalation: 7h/day
- Frequency of treatment:
- Inhalation: 5 days/week for a total of 224 days over an elapsed period of 12 months.
Doses / concentrations
- Remarks:
- Doses / Concentrations:
inhalation: 10 mg/m3
Basis:
analytical conc.
- No. of animals per sex per dose:
- Inhalation: 48 males per substanse (3 test substances + control, altogether 192 animals)
- Control animals:
- yes, concurrent no treatment
- Details on study design:
- INHALATION:
- Dose selection rationale: The dose of 10 mg/m3 of respirable dust was selected to provide a direct comparison with the known effects of prolonged exposure to similar concentrations of asbestos dusts. - Positive control:
- No
Examinations
- Observations and examinations performed and frequency:
- CAGE SIDE OBSERVATIONS: No data
DETAILED CLINICAL OBSERVATIONS: No data
BODY WEIGHT: Yes
- Time schedule for examinations: monthly
FOOD EFFICIENCY:
No data
WATER CONSUMPTION AND COMPOUND INTAKE (if drinking water study): No data
OPHTHALMOSCOPIC EXAMINATION: No data
HAEMATOLOGY: Yes
- Time schedule for collection of blood: 5 days before the start of inhalation and 3 days after the end of the 12 month exposure. period when 12 animals/group were killed.
- Anaesthetic used for blood collection: No data
- Animals fasted: No data
- How many animals: 12 / group, 48 in total
- Parameters checked : haemoglobin and estimation of packed cell volume after hematocrit centrifugation. A more detailed hematological examination was undertaken 12 animals. At the end of the 12 month eposure 12 animals/group (48 rats in total) were killed and haematological analyses were carried out (table 1).
CLINICAL CHEMISTRY: / No data
URINALYSIS: No data
NEUROBEHAVIOURAL EXAMINATION: No data
OTHER: LUNG DUST ANALYSIS
- lungs were available from 6 of the 12 animals/group killed at the end of the exposure period. One lung/animal was assessed
- - Sacrifice and pathology:
- GROSS PATHOLOGY: No data
HISTOPATHOLOGY: Yes
- tissues were taken from all major organs (no details given)
- speciemes were fixed in 10% formal saline and embedded in paraffin wax
- lungs were fixed by instillation prior to excision from the thoracic cavity
- hematoxylin and eosin stainings were routinely used
- for the study of pulmonary fibrosis Van Giesons's stain for collagen or Gordona and Sweet's reticulin stain were used - Statistics:
- No data
Results and discussion
Results of examinations
- Clinical signs:
- no effects observed
- Mortality:
- no mortality observed
- Body weight and weight changes:
- no effects observed
- Food consumption and compound intake (if feeding study):
- not examined
- Food efficiency:
- not examined
- Water consumption and compound intake (if drinking water study):
- not examined
- Ophthalmological findings:
- not examined
- Haematological findings:
- effects observed, treatment-related
- Clinical biochemistry findings:
- not examined
- Urinalysis findings:
- not examined
- Behaviour (functional findings):
- not examined
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Gross pathological findings:
- no effects observed
- Histopathological findings: non-neoplastic:
- effects observed, treatment-related
- Histopathological findings: neoplastic:
- effects observed, treatment-related
- Details on results:
- HAEMATOLOGY: All the examined blood parameters fell within the normal ranges. The only effect was seen related to absolute number of white blood cells, which markedly increased in the dust exposed animal.
HISTOPATHOLOGY: NON-NEOPLASTIC
- All animals treated with calcium silicate materials showed dust-containing macrophages scattered throughout the alveolar regions of the lung, particularly close to the respiratory bronchioles. The frequency of dust-containing macrophages declined substantially after the end of the exposure period.
- Small amounts of interstitial fibrosis were found in 5 control and 13 dusted animals that had survived more than 10 months after the end of the exposure period.
- Animals exposed to sample A tended to have peribronchial areas of fibrosis not found in any of the other groups.
- The mediastinal lymph nodes from all dusted animals were found to contain some particulate material. This amount appeared to increase with time postexposure. Animals exposed to sample A had more extensive changes than the other groups.
OTHER FINDINGS
The lung dust analysis revealed that the lung residues of group C were very similar to those of the controls. The group B residues contained higher amounts of amorphous silica, but no other recognizable minerals. The group A residues contained a mixture of amorphous silica and quartz.
NEOPLASTIC EFFECTS: see Carcinogenicity
Effect levels
- Dose descriptor:
- NOAEC
- Effect level:
- ca. 10 mg/m³ air (analytical)
- Sex:
- male
- Basis for effect level:
- other: No signs of repeated dose toxicity
Target system / organ toxicity
- Critical effects observed:
- not specified
Any other information on results incl. tables
The peribronchial nodules found in animals exposed to sample A were the only pulmonary fibrotic lesions that appeared to be directly related to calcium silicate material exposure. However, these effetcs were supposed to be related to the detected quartz content of the lung dust after exposure to sample A.
The haematological information, indicating no differences between controls and exposed animals in most of the blood parameters, suggest that dust inhalation did not cause any marked systemic toxicity. However, the absolute numbers of white cells were significantly higher in the exposed groups than in the control group. Pulmonary dust accumulation is known to increase the number of neutrophils and macrophages, but there is no evidence that this alone produces changed levels in the numbers of circulating white blood cells. Anyhow this reaction was not considered to be serious, and the total levels were within the normal published range for rats.
Applicant's summary and conclusion
- Conclusions:
- Repeated exposure to calcium silicate dusts did not cause any signs of systemic toxicity. One of the substances tested caused peribronchial nodules, but these were supposed to be related to the higher quartz content of that specific substance (sample A).
- Executive summary:
Male Wistar SPF rats were exposed to three different calcium silicate dusts at a concentration of 10 mg/m3 for 12 months, after which some animals were killed and the others were kept for their full lifespan. Detailed histopathological and haematological examinations were carried out after the animals died.
The haematological information, indicating no differences between controls and exposed animals in most of the blood parameters, suggest that dust inhalation did not cause any marked systemic toxicity.
Peribronchial nodules were found in animals exposed to sample A, but these effetcs were supposed to be related to the detected quartz content of the lung dust after exposure to sample A.
The absolute numbers of white cells were significantly higher in the exposed groups than in the control group. Pulmonary dust accumulation is known to increase the number of neutrophils and macrophages, but there is no evidence that this alone produces changed levels in the numbers of circulating white blood cells. Anyhow this reaction was not considered to be serious, and the total levels were within the normal published range for rats.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.